Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fungal mitochondrial cytochrome b is a key transmembrane subunit of the cytochrome bc1 complex (Complex III), which is essential for the mitochondrial electron transport chain. It functions by mediating the transfer of electrons from ubiquinol to cytochrome c through the Q-cycle mechanism, contributing to the generation of a proton gradient across the inner mitochondrial membrane for ATP production [1][2]. The quinol outer (Qo) site of cytochrome b is a highly conserved pocket that serves as a major target for various agricultural fungicides, such as strobilurins (e.g., azoxystrobin), and clinical antiprotozoals like atovaquone [3][4]. These inhibitors bind to the Qo site, effectively blocking electron transfer and leading to energy depletion and oxidative stress within the fungal or parasitic cell [5]. However, the therapeutic utility of targeting this site is often challenged by the emergence of resistance, primarily driven by single nucleotide polymorphisms in the mitochondrial cob gene, such as the G143A mutation [6]. Understanding the structural biology of the Qo site is crucial for developing next-generation inhibitors that can overcome existing resistance mechanisms while maintaining selectivity over the host's mitochondrial complex [7].
Inhibition of the mitochondrial electron transport chain by binding to the quinol outer (Qo) site of the cytochrome bc1 complex, thereby blocking the oxidation of ubiquinol and preventing the generation of the proton motive force required for ATP synthesis.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome b (mitochondrial) (CYTB) (CYTB).